Smart pens and glucose monitors could transform diabetes care after hospital stay

NCT ID NCT07061301

Recruiting now Disease control Sponsor: Instituto de Investigacion Sanitaria La Fe Source: ClinicalTrials.gov ↗

First seen Jan 24, 2026 · Last updated May 19, 2026 · Updated 15 times

Summary

This study tests whether giving people with type 2 diabetes a continuous glucose monitor and a smart insulin pen cap at hospital discharge helps them stick to their insulin schedule and control blood sugar better. About 80 adults who start insulin while in the hospital will be split into two groups: one sees real-time data from the devices, the other uses standard finger-prick checks. Researchers will track missed doses, time in target blood sugar range, and patient satisfaction over 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hospital La Fe, Valencia
RECRUITING

Valencia, Valencia, 46026, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Contact

Conditions

Explore the condition pages connected to this study.

CGM CONTINUOUS GLUCOSE MONITORING SMART INSULIN PEN CAP TRANSITION TO DISCHARGE TRANSITION TO DISCHARGE TYPE 2 DIABETES MELLITUS (T2DM)